NCT04994509 Pre-Exposure Prophylaxis Study of Lenacapavir and Emtricitabine/Tenofovir Alafenamide in Adolescent Girls and Young Women at Risk of HIV Infection Status ACTIVE_NOT_RECRUITING Phase PHASE3
NCT04980664 Effort to Narrow the Gap Between in Accordance With Guidelines and Consent to Treat CHB Population in East of China Status UNKNOWN Phase NA
NCT04971785 Study of Semaglutide, and Cilofexor/Firsocostat, Alone and in Combination, in Adults With Cirrhosis Due to Nonalcoholic Steatohepatitis (NASH) Status COMPLETED Phase PHASE2
NCT04965662 The Role of Home Packs of HIV PEPSE in High Risk Individuals Status COMPLETED Phase PHASE4
NCT04959643 Systematic Screening for Viral Hepatitis B and C at the PASS Consultation of the Montpellier University Hospital Status UNKNOWN Phase N/A
NCT04958785 Study of Magrolimab Combination Therapy in Patients With Non-Surgically Removable Locally Advanced or Metastatic Triple-Negative Breast Cancer Status TERMINATED Phase PHASE2
NCT04956445 Collection of SARS CoV-2 (COVID-19) Virus Secretions and Serum for Countermeasure Development Status RECRUITING Phase N/A
NCT04952207 Effectiveness and Safety of Direct-Acting Antiviral Agents for the Treatment of Chronic Hepatitis C Status UNKNOWN Phase N/A
NCT04950764 An Open-Label Study Following Oral Dosing of Seladelpar to Participants With Primary Biliary Cholangitis (PBC) and Hepatic Impairment (HI) Status COMPLETED Phase PHASE1
NCT04944654 Efficacy, Tolerability and Acceptability of Biktarvy by TPLWH Status TERMINATED Phase PHASE4
NCT04937881 PK of TAF and TDF for PrEP in Pregnant and Postpartum Women Status COMPLETED Phase PHASE3
NCT04930614 Prevalence and Risk Factors of HIV Infections in Transgender and Non-binary People in Flanders and Brussels (Belgium) Status COMPLETED Phase N/A
NCT04925752 Study of Lenacapavir for HIV Pre-Exposure Prophylaxis in People Who Are at Risk for HIV Infection Status ACTIVE_NOT_RECRUITING Phase PHASE3
NCT04892446 Study of Magrolimab Combinations in Patients With Relapsed/Refractory Multiple Myeloma Status TERMINATED Phase PHASE2
NCT04891770 Study to Evaluate the Safety and Efficacy of Selgantolimod (SLGN)-Containing Combination Therapies for the Treatment of Chronic Hepatitis B (CHB) Status COMPLETED Phase PHASE2
NCT04880577 Tenofovir Alafenamide for Treatment of Symptoms and Neuroprotection in Relapsing Remitting Multiple Sclerosis Status WITHDRAWN Phase PHASE2
NCT04873609 Electronic Record Assimilation and Subsequent Eradication of Hepatitis C Status COMPLETED Phase NA